HUmanitas PROtontherapy (HU-PRO)

计划入组 500 人 · 首次发布于 2026 年 1 月 5 日

Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App

计划入组 33 人 · 首次发布于 2020 年 12 月 19 日

Safety and Efficacy of MEE-HU Medicus

计划入组 200 人 · 首次发布于 2021 年 8 月 26 日

Matrix-M

fibronectin matrix

HU-001

Moerae Matrix, Inc.

United States

Matrix Biomed, Inc.

United States

3-D Matrix Ltd.

Japan

Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance AI-Driven Drug Discovery Platform

Harbour BioMed's AI-Designed LET003 Shows Superior Obesity Treatment Potential in Preclinical Studies

Harbour BioMed Reports Seventh Consecutive Profitable Half-Year, Driven by Strategic Collaborations and AI-Enabled Pipeline Advances